# Rosuvastatin Effect on Telomere-telomerase System in ACS

Study · id `cardio:ct-nct02299245` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02299245](<https://clinicaltrials.gov/study/NCT02299245>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02299245

Browse, organ or system: Heart  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 400 participants.

## Technical summary

Registry record NCT02299245. Randomized; no masking; primary purpose treatment. Start 2014-10 (registry gives no type); primary completion 2016-07 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 400 participants (planned count; ClinicalTrials.gov record NCT02299245, source copy `cardio:ctgov-nct02299245-2015-07-14`, retrieved 2026-10-31)
- Start date: 2014-10 (registry gives no type) (ClinicalTrials.gov record NCT02299245, source copy `cardio:ctgov-nct02299245-2015-07-14`, retrieved 2026-10-31)
- Primary completion: 2016-07 (anticipated) (ClinicalTrials.gov record NCT02299245, source copy `cardio:ctgov-nct02299245-2015-07-14`, retrieved 2026-10-31)
- Completion: 2016-11 (anticipated) (ClinicalTrials.gov record NCT02299245, source copy `cardio:ctgov-nct02299245-2015-07-14`, retrieved 2026-10-31)
- Countries: Not reported
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02299245-2015-07-14`, retrieved 2026-10-31)

## The registry's words

- Brief title: Rosuvastatin Effect on Telomere-telomerase System in ACS
- Condition: Telomere Shortening
- Condition: Telomere Length, Mean Leukocyte
- Condition: 22q Telomere Deletion Syndrome
- Intervention (Drug): rosuvastatin
- Lead sponsor: Xiao-dong Zhuang
- Lead sponsor class: OTHER
- Collaborator: Sun Yat-sen University
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Acute coronary syndrome (`cardio:acute-coronary-syndrome`)
- Registry intervention name matches this record: Rosuvastatin (`cardio:rosuvastatin`)
- Registry intervention is a member of this class by a sourced record link: Statins (`cardio:statins`)
- Registry lists this organization as the lead sponsor: Xiao-dong Zhuang (`cardio:org-xiao-dong-zhuang`)
- Registry lists this organization as a collaborator: Sun Yat-sen University (`cardio:org-sun-yat-sen-university`)

## Provenance

Content hash: 85522ae9088594f59eb6e7e4856b67ca222fd74c82768939ff020bafa6ceb2c0
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
